Search - tctmd.com

Displaying 1 - 20 of 505

Sort: Relevancy | Date

News Conference News ACC 2026

DIG-RHD: Digoxin Effective in Rheumatic Heart Disease

Michael O'Riordan

April 06, 2026

News Daily News

Disparities Widen Across Regions as Global Hypertension Burden Grows

Caitlin E. Cox

April 03, 2026

News Conference News ACC 2026

PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV

Michael O'Riordan

March 29, 2026

News Opinion CV Team Dispatch

March 2026 Dispatch for the CV Team

L.A. McKeown

March 26, 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

News Daily News

No Major Progress on Making CV Care More Affordable: JACC Stats

Todd Neale

March 18, 2026

News Daily News

Lower LDL Levels, Starting Earlier in Life: New ACC/AHA Dyslipidemia Guidelines

Michael O'Riordan

March 13, 2026

News Daily News

Recreational Adderall Causes Worrisome Spikes in BP, Heart Rate

Yael L. Maxwell

March 09, 2026

News Conference News CRT 2026

CRT 2026: What to Expect in Washington, DC

L.A. McKeown

March 04, 2026

News Daily News

Healthy Lifestyle Plus GLP-1s Yields Bigger CV Reduction Than Drugs Alone

Michael O'Riordan

March 03, 2026

News Daily News

Side Effects of Statins Might Be Overstated: CTT Collaboration

Michael O'Riordan

February 12, 2026

News Daily News

Four in Five US Adults With Hypertension Have Uncontrolled BP

Todd Neale

February 03, 2026

News Daily News

HF Care Differs Among Asian Subgroups in the US

L.A. McKeown

January 16, 2026

News Opinion CV Team Dispatch

January 2026 Dispatch for the CV Team

L.A. McKeown

January 16, 2026

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Opinion CV Team Dispatch

December 2025 Dispatch for the CV Team

L.A. McKeown

December 23, 2025

News Daily News

WHO Endorses Treating Obesity in Adults With GLP-1s

Todd Neale

December 01, 2025

News Opinion CV Team Dispatch

November 2025 Dispatch for the CV Team

L.A. McKeown

November 24, 2025

News Opinion CV Team Dispatch

October 2025 Dispatch for the CV Team

L.A. McKeown

October 25, 2025

Advertisement

DIG-RHD: Digoxin Effective in Rheumatic Heart Disease

Disparities Widen Across Regions as Global Hypertension Burden Grows

PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV

March 2026 Dispatch for the CV Team

What’s Going to Be Hot at ACC 2026

No Major Progress on Making CV Care More Affordable: JACC Stats

Lower LDL Levels, Starting Earlier in Life: New ACC/AHA Dyslipidemia Guidelines

Recreational Adderall Causes Worrisome Spikes in BP, Heart Rate

CRT 2026: What to Expect in Washington, DC

Healthy Lifestyle Plus GLP-1s Yields Bigger CV Reduction Than Drugs Alone

Side Effects of Statins Might Be Overstated: CTT Collaboration

Four in Five US Adults With Hypertension Have Uncontrolled BP

HF Care Differs Among Asian Subgroups in the US

January 2026 Dispatch for the CV Team

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

December 2025 Dispatch for the CV Team

WHO Endorses Treating Obesity in Adults With GLP-1s

November 2025 Dispatch for the CV Team

October 2025 Dispatch for the CV Team

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content